Aurobindo Q1 profit up 39.5% at Rs 636 crore on strong revenue growth

Revenue from operations rose 28.1% year-on-year to Rs 5,444.6 crore during the quarter under review

Aurobindo Pharma Limited reported a 39.5 per cent rise in consolidated net profit at Rs 635.8 crore for the quarter ended June 30, 2019, on the back of a strong revenue growth driven by the US formulations business. The company had reported a net profit of Rs 455.7 crore in the quarter ended June 30, 2018. 

Revenue from operations rose 28.1 per cent year-on-year to Rs 5,444.6 crore during the quarter under review from Rs 4,2503 crore in the corresponding quarter of the previous year. On a sequential basis there was a 2.9 per cent rise in revenue, while net